Dr RR Baliga's "Got Knowledge Doc" Podkast

🫀 New insights from EUROMACS registry!

The latest JACC study explores the delicate ⚖️ trade-off between bleeding 🩸 and ischemic 🧠 events in LVAD patients. While HM3 reduces thrombotic risks, bleeding remains the dominant threat. Time to rethink the "one-size-fits-all" anticoagulation 🧪. Personalized strategies like LD-DOACs & lower INR targets may be the next frontier 🚀. Editorial call to action included!

📘 #Cardiology #LVAD #PrecisionMedicine #JACC #HM3 #BleedingRisk #Anticoagulation

👉 Read more & let's discuss.

🧬 New NEJM Review Alert!

MGUS — once "undetermined," now clinically significant.

This comprehensive update by Rajkumar & Kumar reveals how asymptomatic plasma clones may drive renal (MGRS) and neurologic (MGNS) damage 🧠🩺 even without cancer.

🔬 Dive into new diagnostic pathways, risk models (iSTOPMM), and why "watch and wait" no longer fits for all.

📚 A must-read for nephrologists, hematologists, and internists.

#MGUS #MGRS #MGNS #NEJM #Myeloma #PlasmaCellDisorders #MedicalEducation #RenalPathology #Hematology 🧪

🚨 New NEJM Study Alert! 🧬💊

Baxdrostat, a selective aldosterone synthase inhibitor, shows significant BP reduction in patients with resistant & uncontrolled hypertension despite RAAS blockade and diuretic therapy.

✅ SBP ↓ ~9–10 mmHg at 12 weeks

🧂 Targets salt-retaining physiology

⚖️ Well-tolerated: early mild hyperkalemia & hyponatremia

🔁 Durable effect even after withdrawal

A promising step toward precision therapy in tough-to-treat hypertension!

📖 Read more: NEJM Aug 2025 | BaxHTN Trial

#Hypertension #Cardiology #Baxdrostat #Aldosterone #RAAS #NEJM #PrecisionMedicine #ClinicalTrials

🚨 New insights from the SCD-PROTECT Study! 🫀

In a nationwide German cohort of 19,598 patients with newly diagnosed NICM or MI/CAD, early use of the Wearable Cardioverter-Defibrillator (WCD) offered critical protection during the high-risk window of guideline-directed therapy initiation.

📉 Most shocks occurred in the first 200 days

📈 >50% improved LVEF beyond ICD threshold

🛡️ WCD = early shield + risk stratification tool

Let's rethink how we protect vulnerable hearts ❤️‍🔥

#Cardiology #SCD #HeartFailure #WCD #LVEF #ICD #ClinicalResearch #HeartHealth #CardiacArrest #PrecisionMedicine

📢 New JAMA Review Alert! 🦋

Hypothyroidism remains a silent disruptor of health — often underrecognized, yet linked with fatigue 😴, weight gain ⚖️, cardiovascular disease ❤️, and reproductive health challenges 🤰.

This latest JAMA clinical review underscores:

✅ Autoimmunity (Hashimoto thyroiditis) as the leading cause

✅ Lifelong levothyroxine 💊 as first-line therapy

✅ The dangers of both over- and undertreatment ⚖️

✅ When to screen, test, and refer 👩‍⚕️

A must-read for clinicians, researchers, and anyone interested in endocrine health 🌍

🚶‍♀️🏃‍♂️⏱️ Not all movement minutes are created equal!

A major Nature Communications study using data from 73,000+ UK Biobank participants wearing accelerometers found:

1 minute of vigorous activity (VPA) = up to 9 mins moderate (MPA) or 94+ mins light (LPA) for reducing mortality, CVD, diabetes, and cancer risk.

This rewrites the old 1:2 rule and urges updates to global guidelines and wearable health metrics.

📲 Time to upgrade from steps to science.

#NatureCommunications #Wearables #ExerciseScience #PublicHealth #VPA #PrecisionHealth #CardiovascularPrevention #UKBiobank

Hidden Horns 🐏, Silent Signals ⚡, New Memories 🧠

A new Science review reframes the hippocampus beyond the classic trisynaptic loop. Once-overlooked regions like CA2, fasciola cinereum, and indusium griseum — along with enigmatic signals such as small irregular activity (SIA) and dentate spikes (DS) — emerge as crucial for social memory, novelty detection, and arousal states. Far from "junk activity," these dynamics expand our map of hippocampal computation with deep clinical implications.

🚨 Just read the latest Lancet 2025 Seminar on Large-Vessel Vasculitis – a must-read for anyone tracking 🔍 Giant Cell Arteritis, 💥 Takayasu Arteritis, and 🧬 Isolated Aortitis. From 🚑 clinical phenotypes to 🧠 imaging advances and 🎯 targeted biologics like tocilizumab and JAK inhibitors, this article bridges inflammation with innovation.

📸 Vascular imaging, 🔬 immunopathology, and 🧪 new therapies—essential insights for rheumatology, cardiology & internal medicine teams.

📖 Read it, teach it, share it! #Vasculitis #GCA #TAK #Immunology #PrecisionMedicine #Lancet2025

🍬 Can sweeteners help you stay slim?

A new 1-year multicenter RCT in Nature Metabolism shows that replacing sugar with sweeteners & sweetness enhancers supports modest weight loss maintenance ⚖️ and beneficial gut microbiota shifts 🦠—with no adverse cardiometabolic effects 💓.

🚫 Less sugar, ✔️ better weight control, 🧬 smarter microbiota.

The future of precision nutrition may be sweet after all!

🔗 #NatureMetabolism #Obesity #Microbiome #Sweeteners #RCT #WeightLoss #NutritionScience #PrecisionHealth #Cardiology #GutHealth

🚨 Just out in NEJM! In the Phase 3 HYPERION trial, adding sotatercept early in pulmonary arterial hypertension (PAH) slashed clinical worsening risk by 76% vs placebo (HR 0.24, P

💡 Benefits appeared after just 3 doses, with improved 6-min walk, NT-proBNP, and risk scores. Most AEs were mild (epistaxis, telangiectasia).

📊 A game-changer in early PAH therapy. NNT = 5 over 12 months.

🔗 #Cardiology #PulmonaryHypertension #Sotatercept #NEJM #PrecisionMedicine #ClinicalTrials #RightHeart #TGFb #REVEAL #COMPERA